SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India - Quaterly Results

24 Jan 2025 Evaluate
Net sales declined -14.45%  to  Rs. 8421.96 million from Rs. 9844.85 millions.A big decline of -36.86% was reported for the quarter ended December 2024 to Rs. 901.11  millions from Rs. 1427.05 millions of corresponding previous quarter.Operating Profit reported a sharp decline to 1734.78 millions from 2475.50 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 8421.96 9844.85 -14.45 22621.37 28149.00 -19.64 37550.91 39312.00 -4.48
Other Income 56.07 6.66 741.89 101.95 23.52 333.46 57.77 99.32 -41.83
PBIDT 1734.78 2475.50 -29.92 4580.84 6144.31 -25.45 8071.37 8481.71 -4.84
Interest 172.14 197.79 -12.97 492.93 522.13 -5.59 719.98 386.74 86.17
PBDT 1562.64 2277.71 -31.39 4087.91 5622.18 -27.29 7351.39 8094.97 -9.19
Depreciation 376.63 361.59 4.16 1082.57 1074.38 0.76 1438.48 1455.57 -1.17
PBT 1186.01 1916.12 -38.10 3005.34 4547.80 -33.92 5912.91 6639.40 -10.94
TAX 284.90 489.07 -41.75 752.52 1160.78 -35.17 1553.73 1651.55 -5.92
Deferred Tax 16.54 34.50 -52.06 41.91 81.89 -48.82 47.68 -50.51 -194.40
PAT 901.11 1427.05 -36.86 2252.82 3387.02 -33.49 4359.18 4987.85 -12.60
Equity 242.49 242.37 0.05 242.49 242.37 0.05 242.37 242.04 0.14
PBIDTM(%) 20.60 25.15 -18.08 20.25 21.83 -7.23 21.49 21.58 -0.37

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×